A Study of IDE849 in People With Solid Tumor Cancer

Full Title

A Multicenter Study Evaluating the Safety, Efficacy, And Pharmacokinetics of IDE849 in Patients with DLL3 Expressing Tumors Including Small Cell Lung Cancer

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Jessica Ross’ office at 646-608-4422.

Protocol
26-235
Phase
Phase I/II (phases 1 and 2 combined)
Disease Status
Relapsed or Refractory
Investigator
Jessica Ross
Co-Investigators
Gopa Iyer
Diseases
Lung Cancer › Lung Cancer, Small Cell
Lung Cancer, Small Cell › Other
Solid Tumors
Upper Gastrointestinal › Neuroendocrine
Locations
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau
ClinicalTrials.gov ID
NCT07174583
ClinicalTrials.gov
Visit ClinicalTrials.gov for full clinical trial description